C Difficile

9625 bookmarks
Custom sorting
Manipulation of the intestinal microbiome-a slow journey to primetime - PubMed
Manipulation of the intestinal microbiome-a slow journey to primetime - PubMed
The gut microbiota has important functions in the regulation of normal body functions. Alterations of the microbiota are being increasingly linked to various disease states. The microbiome has been manipulated via the administration of stool from animals or humans, for more than 1000 years. C …
·pubmed.ncbi.nlm.nih.gov·
Manipulation of the intestinal microbiome-a slow journey to primetime - PubMed
Current Therapeutics in Primary Sclerosing Cholangitis - PubMed
Current Therapeutics in Primary Sclerosing Cholangitis - PubMed
Primary sclerosing cholangitis (PSC) is an orphan, cholestatic liver disease that is characterized by inflammatory biliary strictures with variable progression to end-stage liver disease. Its pathophysiology is poorly understood. Chronic biliary inflammation is likely driven by immune dysregulation, …
·pubmed.ncbi.nlm.nih.gov·
Current Therapeutics in Primary Sclerosing Cholangitis - PubMed
Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans - PubMed
Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans - PubMed
Off-the-shelf FMT requires recipient-independent optimized FMT selection. Such a transplant can be from an optimal donor or from a cultured set of microbes. We have here shown the feasibility of both types of manipulations in mouse and human recipients. Video Abstract.
·pubmed.ncbi.nlm.nih.gov·
Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans - PubMed
Antibiotic Stewardship in Urologic Infections - George Koch
Antibiotic Stewardship in Urologic Infections - George Koch
In this conversation, host Ruchika Talwar is joined by George Koch to discuss the importance of antibiotic stewardship in urology, exploring the reduction of unnecessary antibiotic loads in treating infections like Fournier's gangrene and recurrent UTIs. Dr. Koch emphasizes the careful selection and timing of antibiotics in perioperative prophylaxis and other conditions. Dr. Talwar points out...
·news.google.com·
Antibiotic Stewardship in Urologic Infections - George Koch
No Association Found Between COVID-19 Pandemic and Incidence of Health Care-Associated C. Difficile Infections
No Association Found Between COVID-19 Pandemic and Incidence of Health Care-Associated C. Difficile Infections
Prior studies had produced conflicting results on whether the pandemic positively or negatively impacted health care-associated C. difficile infections, yet the results of this current study indicate the pandemic played a limited role.
·news.google.com·
No Association Found Between COVID-19 Pandemic and Incidence of Health Care-Associated C. Difficile Infections
Microbiome and microbial therapy advances: takeaways from the Digestive Disease Week 2023
Microbiome and microbial therapy advances: takeaways from the Digestive Disease Week 2023
The Digestive Disease Week meeting 2023 covered a considerable variety of basic, translational, and clinical aspects of research in gastrointestinal and extraintestinal human health and disease. This post highlights the major takeaways from the Microbiome & Microbial Therapy sessions and unravels how they might impact daily basic research and clinical practice (part 2).
·gutmicrobiotaforhealth.com·
Microbiome and microbial therapy advances: takeaways from the Digestive Disease Week 2023
Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection - PubMed
Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection - PubMed
Our data indicate that different external and internal factors drive comparable profiles of low diversity dysbiosis. While diarrheal-related low diversity dysbiosis may be a consequence of systemic cancer therapy, a similar phenotype is observed in cases of moderate to severe IBD, and in both cases, …
·pubmed.ncbi.nlm.nih.gov·
Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection - PubMed
Clostridium Diagnostics Market Poised to Achieve US$7.8 Billion by 2032 with a Striking 12.2% CAGR
Clostridium Diagnostics Market Poised to Achieve US$7.8 Billion by 2032 with a Striking 12.2% CAGR
The global Clostridium Diagnostics Market is anticipated to grow at a 12.2% CAGR from 2022 to 2032, from US$ 2.5 billion to US$ 7.8 billion. The market saw a 13.6% CAGR between 2015 and 2021. The market is expanding as a result of increased awareness-raising activities for clostridium-related ill...
·news.google.com·
Clostridium Diagnostics Market Poised to Achieve US$7.8 Billion by 2032 with a Striking 12.2% CAGR
Healthcare-Associated Clostridioides difficile Infection: Learning the Perspectives of Healthcare Workers to Build Successful Strategies - PubMed
Healthcare-Associated Clostridioides difficile Infection: Learning the Perspectives of Healthcare Workers to Build Successful Strategies - PubMed
Our findings emphasize the importance of including frontline healthcare personnel in infection prevention decision-making processes and the strategies presented here can be applied to mitigating infections in different healthcare settings.
·pubmed.ncbi.nlm.nih.gov·
Healthcare-Associated Clostridioides difficile Infection: Learning the Perspectives of Healthcare Workers to Build Successful Strategies - PubMed
Evaluation of a two step testing algorithm to improve diagnostic accuracy and stewardship of Clostridioides difficile infections - PubMed
Evaluation of a two step testing algorithm to improve diagnostic accuracy and stewardship of Clostridioides difficile infections - PubMed
In response to national guidelines, we implemented a two-step testing algorithm for Clostridioides difficile in an effort to improve diagnostic accuracy. Following implementation, we analyzed treatment frequency between discordant and concordant patients. We found that the majority of discordant cas …
·pubmed.ncbi.nlm.nih.gov·
Evaluation of a two step testing algorithm to improve diagnostic accuracy and stewardship of Clostridioides difficile infections - PubMed
Age-dependent modulation of gut microbiome in response to tumor immunomodulation - PubMed
Age-dependent modulation of gut microbiome in response to tumor immunomodulation - PubMed
In-situ vaccination (ISV) utilizing nanoparticles (NPs) and therapeutic devices like focused ultrasound (FUS) can trigger immune-mediated killing of both treated and untreated cancer cells. However, the impact of confounding factors such as aging and gut microbiota composition on therapeutic outcome …
·pubmed.ncbi.nlm.nih.gov·
Age-dependent modulation of gut microbiome in response to tumor immunomodulation - PubMed
Aged gut microbiota contribute to different changes in antioxidant defense in the heart and liver after transfer to germ-free mice - PubMed
Aged gut microbiota contribute to different changes in antioxidant defense in the heart and liver after transfer to germ-free mice - PubMed
Age-associated impairment in antioxidant defense is an important cause of oxidative stress, and elderly individuals are usually associated with gut microbiota (GM) changes. Studies have suggested a potential relationship between the GM and changes in antioxidant defense in aging animals. Direct evid …
·pubmed.ncbi.nlm.nih.gov·
Aged gut microbiota contribute to different changes in antioxidant defense in the heart and liver after transfer to germ-free mice - PubMed
A Comparison of Methods of Gut Microbiota Transplantation for Preclinical Studies - PubMed
A Comparison of Methods of Gut Microbiota Transplantation for Preclinical Studies - PubMed
The experimental details reported in preclinical fecal microbiota transplantation (FMT) protocols are highly inconsistent, variable, and/or incomplete. We therefore evaluated FMT from a human donor to antibiotic-induced microbial-depleted mice by exploring the effects of six techniques based on anti …
·pubmed.ncbi.nlm.nih.gov·
A Comparison of Methods of Gut Microbiota Transplantation for Preclinical Studies - PubMed
The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation - PubMed
The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation - PubMed
(1) Background: Fecal microbiota transplantation (FMT) is an effective treatment for ulcerative colitis (UC). Metabolomic techniques would assist physicians in clinical decision-making. (2) Methods: Patients with active UC undergoing FMT were enrolled in the study and monitored for 3 months. We expl …
·pubmed.ncbi.nlm.nih.gov·
The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation - PubMed
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review - PubMed
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review - PubMed
Neurogenic hypertension, a complex and multifactorial cardiovascular disorder, is known to be influenced by various genetic, environmental, and lifestyle factors. In recent years, there has been growing interest in the role of the gut microbiome in hypertension pathogenesis. The bidirectional commun …
·pubmed.ncbi.nlm.nih.gov·
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review - PubMed
The role of microbiome-based therapeutics for antimicrobial-resistant organism colonization - PubMed
The role of microbiome-based therapeutics for antimicrobial-resistant organism colonization - PubMed
The gut is host to a diverse array of microbiota that constitute a complex ecological system crucial to human physiology. Disruptors to the normal host microbiota, such as antimicrobials, can cause a loss of species diversity in the gut, reducing its ability to resist colonization by invading pathog …
·pubmed.ncbi.nlm.nih.gov·
The role of microbiome-based therapeutics for antimicrobial-resistant organism colonization - PubMed
Case report of SARS-CoV-2 with secondary Clostridioides difficile infection - PubMed
Case report of SARS-CoV-2 with secondary Clostridioides difficile infection - PubMed
There has been an overuse of antibiotics in most patients suffering from COVID-19 which predisposes patients to hospital acquired C. difficile Infection (CDI). Also, COVID infection of the gastrointestinal tract also predisposes the patient to CDI. We here present a fatal case of SARS-CoV-2 coinfect …
·pubmed.ncbi.nlm.nih.gov·
Case report of SARS-CoV-2 with secondary Clostridioides difficile infection - PubMed
Clostridioides difficile and Enterococci's Interplay in the Human Gut: Bacterial Alliance or Competition? A Systematic Literature Review - PubMed
Clostridioides difficile and Enterococci's Interplay in the Human Gut: Bacterial Alliance or Competition? A Systematic Literature Review - PubMed
Clostridioides difficile and Enterococcus spp. are two common bacterial pathogens populating the human microbiota. We possess scant data on how Clostridioides difficile interacts with Enterococcus spp. in the gut microbiota in subjects colonized with Clostridioides dif …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile and Enterococci's Interplay in the Human Gut: Bacterial Alliance or Competition? A Systematic Literature Review - PubMed
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial - PubMed
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial - PubMed
ClinicalTrials.gov NCT03244644 (https://clinicaltrials.gov/ct2/show/NCT03244644).
·pubmed.ncbi.nlm.nih.gov·
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial - PubMed
FDA-approved microbiome therapy reduces recurrent CDI, regardless of risk factors
FDA-approved microbiome therapy reduces recurrent CDI, regardless of risk factors
An FDA-approved oral fecal microbiota therapeutic reduces the risk for recurrent Clostridioides difficile infection in high-risk patients compared with placebo, regardless of demographics or baseline risk factors, researchers reported.
·news.google.com·
FDA-approved microbiome therapy reduces recurrent CDI, regardless of risk factors